Anesthesiology and Pain Medicine

Published by: Kowsar

The Effect of Chronic Consumption of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Antagonists on Blood Pressure and Inotrope Consumption After Separation from Cardiopulmonary Bypass

Ebrahim Hassani 1 , Alireza Mahoori 1 , Nazli Karami 1 , * , Asma Hassani 1 and Leila Hassani 1
Authors Information
1 Department of Anesthesiology, Urmia University of Medical Sciences, Urmia, Iran
Article information
  • Anesthesiology and Pain Medicine: 8 (3); e74026
  • Published Online: June 20, 2018
  • Article Type: Research Article
  • Received: April 29, 2018
  • Revised: May 28, 2018
  • Accepted: June 2, 2018
  • DOI: 10.5812/aapm.74026

To Cite: Hassani E, Mahoori A, Karami N, Hassani A, Hassani L. The Effect of Chronic Consumption of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Antagonists on Blood Pressure and Inotrope Consumption After Separation from Cardiopulmonary Bypass, Anesth Pain Med. Online ahead of Print ; 8(3):e74026. doi: 10.5812/aapm.74026.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Heart Outcomes Prevention Evaluation Study I, Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342(3):145-53. doi: 10.1056/NEJM200001203420301. [PubMed: 10639539].
  • 2. Coriat P, Richer C, Douraki T, Gomez C, Hendricks K, Giudicelli JF, et al. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology. 1994;81(2):299-307. doi: 10.1097/00000542-199408000-00006. [PubMed: 8053578].
  • 3. Bertrand M, Godet G, Meersschaert K, Brun L, Salcedo E, Coriat P. Should the angiotensin II antagonists be discontinued before surgery? Anesth Analg. 2001;92(1):26-30. doi: 10.1097/00000539-200101000-00006. [PubMed: 11133595].
  • 4. Kheterpal S, Khodaparast O, Shanks A, O'Reilly M, Tremper KK. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery. J Cardiothorac Vasc Anesth. 2008;22(2):180-6. doi: 10.1053/j.jvca.2007.12.020. [PubMed: 18375317].
  • 5. Sun JZ, Cao LH, Liu H. ACE inhibitors in cardiac surgery: current studies and controversies. Hypertens Res. 2011;34(1):15-22. doi: 10.1038/hr.2010.188. [PubMed: 20944641].
  • 6. Mahoori A, Hassani E, Karami N, Azizpoure M. [Comparison of gabapentin, pregabalin and placebo as premedication for attenuation of hemodynamic response to laryngoscopy and endotracheal intubation]. Tehran Univ Med J. 2017;75(5):367-73. Persian.
  • 7. Mahoori A, Noroozinia H, Hasani E, Karami N, Pashaei N, Hatami S. The effect of low-dose remifentanil on the hemodynamic responses of endotracheal extubation. Acta Med Iran. 2014;52(11):844-7. [PubMed: 25415818].
  • 8. Steely AM, Callas PW, Bertges DJ, Vascular Study Group of New E. Renin-angiotensin-aldosterone-system inhibition is safe in the preoperative period surrounding carotid endarterectomy. J Vasc Surg. 2016;63(3):715-21. doi: 10.1016/j.jvs.2015.09.048. [PubMed: 26603543].
  • 9. Ouzounian M, Buth KJ, Valeeva L, Morton CC, Hassan A, Ali IS. Impact of preoperative angiotensin-converting enzyme inhibitor use on clinical outcomes after cardiac surgery. Ann Thorac Surg. 2012;93(2):559-64. doi: 10.1016/j.athoracsur.2011.10.058. [PubMed: 22269723].
  • 10. Zhang Y, Ma L. Effect of preoperative angiotensin-converting enzyme inhibitor on the outcome of coronary artery bypass graft surgery. Eur J Cardiothorac Surg. 2015;47(5):788-95. doi: 10.1093/ejcts/ezu298. [PubMed: 25079771].
  • 11. Sharafi A, Davoodi S, Karimi AA, Ahmadi H, Abbasi K, Sheikh Fathollahi M, et al. Impact of Angiotensin-converting enzyme inhibitors and Angiotensin receptor blockers on mortality of coronary artery bypass grafting. J Tehran Heart Cent. 2013;8(4):177-81. [PubMed: 26005485]. [PubMed Central: PMC4434968].
  • 12. Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 2003;75(2):S715-20. doi: 10.1016/S0003-4975(02)04701-X. [PubMed: 12607717].
  • 13. Oh YJ, Lee JH, Nam SB, Shim JK, Song JH, Kwak YL. Effects of chronic angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor treatments on neurohormonal levels and haemodynamics during cardiopulmonary bypass. Br J Anaesth. 2006;97(6):792-8. doi: 10.1093/bja/ael268. [PubMed: 17032660].
  • 14. Shahzamani M, Yousefi Z, Frootaghe AN, Jafarimehr E, Froughi M, Tofighi F, et al. The effect of angiotensin-converting enzyme inhibitor on hemodynamic instability in patients undergoing cardiopulmonary bypass: results of a dose-comparison study. J Cardiovasc Pharmacol Ther. 2009;14(3):185-91. doi: 10.1177/1074248409341879. [PubMed: 19721131].
  • 15. Kinoshita T, Asai T. Role of renin-angiotensin system inhibitors in patients undergoing off-pump coronary artery bypass grafting. Circ J. 2010;74(9):1800-1. doi: 10.1253/circj.CJ-10-0704. [PubMed: 20702952].
  • 16. Barodka V, Silvestry S, Zhao N, Jiao X, Whellan DJ, Diehl J, et al. Preoperative renin-angiotensin system inhibitors protect renal function in aging patients undergoing cardiac surgery. J Surg Res. 2011;167(2):e63-9. doi: 10.1016/j.jss.2009.11.702. [PubMed: 20189597].
  • 17. Pigott DW, Nagle C, Allman K, Westaby S, Evans RD. Effect of omitting regular ACE inhibitor medication before cardiac surgery on haemodynamic variables and vasoactive drug requirements. Br J Anaesth. 1999;83(5):715-20. doi: 10.1093/bja/83.5.715. [PubMed: 10690132].
  • 18. Hasija S, Makhija N, Choudhury M, Hote M, Chauhan S, Kiran U. Prophylactic vasopressin in patients receiving the angiotensin-converting enzyme inhibitor ramipril undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2010;24(2):230-8. doi: 10.1053/j.jvca.2009.08.001. [PubMed: 19875309].
  • 19. Deakin CD, Dalrymple-Hay MJ, Jones P, Monro JL. Effects of angiotensin converting enzyme inhibition on systemic vascular resistance and vasoconstrictor requirements during hypothermic cardiopulmonary bypass. Eur J Cardiothorac Surg. 1998;13(5):546-50. doi: 10.1016/S1010-7940(98)00051-7. [PubMed: 9663536].
  • 20. Devbhandari MP, Balasubramanian SK, Codispoti M, Nzewi OC, Prasad SU. Preoperative angiotensin-converting enzyme inhibition can cause severe post CPB vasodilation--current UK opinion. Asian Cardiovasc Thorac Ann. 2004;12(4):346-9. doi: 10.1177/021849230401200414. [PubMed: 15585706].
  • 21. Ren Y, Lindemann DC, Thomas RJ, Baghelai K, Durham SJ. High flow and high dose neosynephrine are effective to maintain perfusion pressure for the patient with preoperative angiotensin converting enzyme inhibitor during cardiopulmonary bypass. J Extra Corpor Technol. 2012;44(2):66-8. [PubMed: 22893985]. [PubMed Central: PMC4557453].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments